BriefScience

Free genealogy & DNA research help at your local library

·25 Aug
Share:PostShare
N

Newsbreak

Original source

Read full story

Related Stories

Science1h ago

AI Proteins Announces Research Collaboration and License Agreement With Astellas Pharma to Discover and Develop Novel Miniprotein-Based Therapeutics Valued at Over $400 Million

BOSTON--(BUSINESS WIRE)--AI Proteins, Inc., a biotechnology company that utilizes computational de novo protein design to create therapeutic miniproteins, today announced it has entered into a Research Collaboration and License Agreement with Astellas Innovation Management LLC, an affiliate of Astellas Pharma Inc. (TSE: 4503), to discover and develop novel miniprotein-based therapeutics. Under the terms of the agreement, AI Proteins is eligible to receive over $400 million in upfront and milest

BBusinesswire

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer